Low-Cost Transcriptional Diagnostic Accurately Categorizes Lymphomas
|
By LabMedica International staff writers Posted on 14 Jun 2021 |
|
Image: An automated Leica BOND-III immunostainer (Photo courtesy of Leica Biosystems)
Lymphoma is a cancer of the lymphatic system, which is part of the body's germ-fighting network. The lymphatic system includes the lymph nodes (lymph glands), spleen, thymus gland and bone marrow. Lymphoma can affect all those areas as well as other organs throughout the body.
Many subtypes of lymphoma can be effectively treated with available therapies, including chemotherapies, monoclonal antibodies, or small molecule–targeted agents. As a result, there is a pressing need for inexpensive, accurate, and operator-independent diagnostics to guide therapeutic selection for patients with lymphoma.
An international team of medical scientists led by the Fred Hutchinson Cancer Research Center (Seattle, WA, USA) collected Formalin-fixed Paraffin-embedded (FFPE) biopsy specimens obtained at Instituto de Cancerología y Hospital Dr. Bernardo Del Valle (INCAN, Guatemala City, Guatemala), that were performed because of clinical suspicion of lymphoma over a 13-year period. This included 3,015 tissue blocks from 1,836 individual patients. Most biopsy specimens were from lymph nodes or secondary lymphoid tissue, but additional extranodal sites (e.g., palate, testicle, eyelid, femur, thyroid, skin, mesentery, tongue, breast, and lung) were included.
One-half of each FFPE block and H&E slides were generated from whole sections and reviewed by two expert hematopathologists. Representative areas were selected, and two cores from each sample were included for tissue microarray (TMA) construction. TMAs were sectioned at 4-μm thickness and subjected to immunohistochemistry (IHC) per routine protocol on automated Leica BOND-III immunostainers (Leica Biosystems, Buffalo Grove, IL, USA) or BenchMark ULTRA, Roche/Ventana Medical Systems, Tucson, AZ, USA). Capillary electrophoresis was run on an Applied Biosystems 3500 or SeqStudio Genetic Analyzer (Thermo Fisher Scientific, Waltham, MA, USA).
The team established a chemical ligation probe-based assay (CLPA) that quantifies expression of 37 genes by capillary electrophoresis with reagent/consumable cost of approximately USD 10/sample. To assign bins based on gene expression, 13 models were evaluated as candidate base learners, and class probabilities from each model were then used as predictors in an extreme gradient boosting super learner. Cases with call probabilities < 60% were classified as indeterminate. Four (2%) of 194 biopsy specimens in storage <3 years experienced assay failure. Diagnostic samples were divided into 397 (70%) training and 163 (30%) validation cohorts. Overall accuracy for the validation cohort was 86%.
After excluding 28 (17%) indeterminate calls, accuracy increased to 94%. Concordance was 97% for a set of 37 high-probability calls assayed by CLPA in both the USA and Guatemala. Accuracy for a cohort of 39 relapsed/refractory biopsy specimens was 79% and 88%, respectively, after excluding indeterminate cases. Machine-learning analysis of gene expression accurately classifies paraffin-embedded lymphoma biopsy specimens and could transform diagnosis in lower- and middle-income countries. The study was published on May 14, 2021 in the journal Blood Advances.
Related Links:
Fred Hutchinson Cancer Research Center
Instituto de Cancerología y Hospital Dr. Bernardo Del Valle
Leica Biosystems
Roche/Ventana Medical Systems
Thermo Fisher Scientific
 Reagent.jpg)
Many subtypes of lymphoma can be effectively treated with available therapies, including chemotherapies, monoclonal antibodies, or small molecule–targeted agents. As a result, there is a pressing need for inexpensive, accurate, and operator-independent diagnostics to guide therapeutic selection for patients with lymphoma.
An international team of medical scientists led by the Fred Hutchinson Cancer Research Center (Seattle, WA, USA) collected Formalin-fixed Paraffin-embedded (FFPE) biopsy specimens obtained at Instituto de Cancerología y Hospital Dr. Bernardo Del Valle (INCAN, Guatemala City, Guatemala), that were performed because of clinical suspicion of lymphoma over a 13-year period. This included 3,015 tissue blocks from 1,836 individual patients. Most biopsy specimens were from lymph nodes or secondary lymphoid tissue, but additional extranodal sites (e.g., palate, testicle, eyelid, femur, thyroid, skin, mesentery, tongue, breast, and lung) were included.
One-half of each FFPE block and H&E slides were generated from whole sections and reviewed by two expert hematopathologists. Representative areas were selected, and two cores from each sample were included for tissue microarray (TMA) construction. TMAs were sectioned at 4-μm thickness and subjected to immunohistochemistry (IHC) per routine protocol on automated Leica BOND-III immunostainers (Leica Biosystems, Buffalo Grove, IL, USA) or BenchMark ULTRA, Roche/Ventana Medical Systems, Tucson, AZ, USA). Capillary electrophoresis was run on an Applied Biosystems 3500 or SeqStudio Genetic Analyzer (Thermo Fisher Scientific, Waltham, MA, USA).
The team established a chemical ligation probe-based assay (CLPA) that quantifies expression of 37 genes by capillary electrophoresis with reagent/consumable cost of approximately USD 10/sample. To assign bins based on gene expression, 13 models were evaluated as candidate base learners, and class probabilities from each model were then used as predictors in an extreme gradient boosting super learner. Cases with call probabilities < 60% were classified as indeterminate. Four (2%) of 194 biopsy specimens in storage <3 years experienced assay failure. Diagnostic samples were divided into 397 (70%) training and 163 (30%) validation cohorts. Overall accuracy for the validation cohort was 86%.
After excluding 28 (17%) indeterminate calls, accuracy increased to 94%. Concordance was 97% for a set of 37 high-probability calls assayed by CLPA in both the USA and Guatemala. Accuracy for a cohort of 39 relapsed/refractory biopsy specimens was 79% and 88%, respectively, after excluding indeterminate cases. Machine-learning analysis of gene expression accurately classifies paraffin-embedded lymphoma biopsy specimens and could transform diagnosis in lower- and middle-income countries. The study was published on May 14, 2021 in the journal Blood Advances.
Related Links:
Fred Hutchinson Cancer Research Center
Instituto de Cancerología y Hospital Dr. Bernardo Del Valle
Leica Biosystems
Roche/Ventana Medical Systems
Thermo Fisher Scientific
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
Channels
Clinical Chemistry
view channel
3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more.jpg "Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)")
POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more
Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
The conventional methods for measuring free cortisol, the body's stress hormone, from blood or saliva are quite demanding and require sample processing. The most common method, therefore, involves collecting... Read more
Molecular Diagnostics
view channel
Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
Two studies have identified proteins in the blood that could potentially alert individuals to the presence of cancer more than seven years before the disease is clinically diagnosed. Researchers found... Read more (1)_1.jpg "Image: Ultrasound image of micro-histotripsy liberation of biomarkers in a tumor (Photo courtesy of Joy Wang and Pradyumna Kedarisetti)"){kind=small}
Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
Ultrasound imaging serves as a noninvasive method to locate and monitor cancerous tumors effectively. However, crucial details about the cancer, such as the specific types of cells and genetic mutations... Read more_1.jpg "Image: The innovative method to customize and strengthen DNA origami structure promises breakthroughs in medicine (Photo courtesy of Shutterstock)")
.jpg "Image: The QIAstat-Dx Respiratory Panel Plus has received U.S. FDA clearance (Photo courtesy of QIAGEN)")
Immunology
view channel.jpg "Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)")
AI Predicts Tumor-Killing Cells with High Accuracy
Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more
Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more
Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read moreMicrobiology
view channel
Integrated Solution Ushers New Era of Automated Tuberculosis Testing
Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
Sepsis affects up to 50 million people globally each year, with bacteraemia, formerly known as blood poisoning, being a major cause. In the United States alone, approximately two million individuals are... Read more
Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more
Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
Antimicrobial resistance (AMR) is a serious global public health concern that claims millions of lives every year. It primarily results from the inappropriate and excessive use of antibiotics, which reduces... Read morePathology
view channel
Hyperspectral Dark-Field Microscopy Enables Rapid and Accurate Identification of Cancerous Tissues
Breast cancer remains a major cause of cancer-related mortality among women. Breast-conserving surgery (BCS), also known as lumpectomy, is the removal of the cancerous lump and a small margin of surrounding tissue.... Read more
AI Advancements Enable Leap into 3D Pathology
Human tissue is complex, intricate, and naturally three-dimensional. However, the thin two-dimensional tissue slices commonly used by pathologists to diagnose diseases provide only a limited view of the... Read more
New Blood Test Device Modeled on Leeches to Help Diagnose Malaria
Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more
Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing
Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read moreTechnology
view channel
New Diagnostic System Achieves PCR Testing Accuracy
While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read more
DNA Biosensor Enables Early Diagnosis of Cervical Cancer
Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community.... Read more
Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
Microfluidics, which are miniature devices that control the flow of liquids and facilitate chemical reactions, play a key role in disease detection from small samples of blood or other fluids.... Read more
Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued... Read moreIndustry
view channel
Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis
Unlike severe traumatic brain injury (TBI), mild TBI often does not show clear correlations with abnormalities detected through head computed tomography (CT) scans. Consequently, there is a pressing need... Read more
Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
Beckman Coulter Diagnostics (Brea, CA, USA) and MeMed BV (Haifa, Israel) have expanded their host immune response diagnostics partnership. Beckman Coulter is now an authorized distributor of the MeMed... Read more_1.jpg "Image: Thermo Fisher will distribute Bio-Techne products across Europe (Photo courtesy of 123RF)")
